MedPath

Detection of Testosterone Microdosing in Healthy Me

Phase 4
Conditions
Doping in sports
Metabolic and Endocrine - Normal metabolism and endocrine development and function
Registration Number
ACTRN12619001506189
Lead Sponsor
Sydney local Health District
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Stopped early
Sex
Male
Target Recruitment
6
Inclusion Criteria

•Healthy men aged over 18 years of age
•Provide written, informed consent and willing to comply with all study requirements

Exclusion Criteria

•Contraindications to testosterone administration (prostate or breast cancer, untreated sleep apnea or polycythemia)
•Allergy to peanuts
•Bleeding disorder or taking anti-coagulant drugs
•Major, serious or chronic medical disorders including chronic viral infections (HIV, hepatitis) requiring regular prescribed medication;
•Regular use of medications that interferes with metabolism of testosterone
•History of androgen or other drug abuse within last year
•Major psychiatric disease or psychological condition that limits understanding and compliance with study requirements in the opinion of the investigator
•Men in competitive sporting teams subject to WADA or other occupational drug testing that would disclose testosterone administration

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath